ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors OK Expansion Of Science Enrichment Program, Other Concepts

November 1, 1991

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget

February 20, 1987

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995